Covid-19: Trump sought to buy vaccine developer exclusively for US, say German officials
Owen Dyer
Abstract
The US president, Donald Trump, made secret overtures to the German company CureVac—one of the leading contenders to create a covid-19 vaccine—in the hope of luring it to the United States, say senior officials in the German government. Germany’s Welt am Sonntag newspaper reported that the offer, valued at about $1bn (£829m; €912m), stipulated that any vaccine the company developed would be “only for the USA.”1 The company has often said that its products would be offered to all countries. Senior German officials confirmed the reports and criticised the US government’s actions. Horst Seehofer, interior minister, when asked to confirm the newspaper’s report, said that he had “heard from several other …
Topics & Concepts
GermanNewspaperGerman governmentGovernment (linguistics)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakPolitical scienceSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)LawManagementMedicineHistoryVirologyOutbreakEconomicsArchaeologyPhilosophyInfectious disease (medical specialty)PathologyLinguisticsDiseaseHealthcare Systems and ChallengesGlobal Public Health Policies and Epidemiology